Tumor Energy Metabolism and Potential of 3-Bromopyruvate as an Inhibitor of Aerobic Glycolysis: Implications in Tumor Treatment
出版年份 2019 全文链接
标题
Tumor Energy Metabolism and Potential of 3-Bromopyruvate as an Inhibitor of Aerobic Glycolysis: Implications in Tumor Treatment
作者
关键词
-
出版物
Cancers
Volume 11, Issue 3, Pages 317
出版商
MDPI AG
发表日期
2019-03-07
DOI
10.3390/cancers11030317
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of clinically node-negative non-small cell lung cancer
- (2019) Yusuke Takahashi et al. Thoracic Cancer
- Suppression of Tumor Energy Supply by Liposomal Nanoparticle-Mediated Inhibition of Aerobic Glycolysis
- (2018) Yinlong Zhang et al. ACS Applied Materials & Interfaces
- Synergistic in-vitro effects of combining an antiglycolytic, 3-bromopyruvate, and a bromodomain-4 inhibitor on U937 myeloid leukemia cells
- (2018) Nicolette Kapp et al. ANTI-CANCER DRUGS
- Protective and recuperative effects of 3-bromopyruvate on immunological, hepatic and renal homeostasis in a murine host bearing ascitic lymphoma: Implication of niche dependent differential roles of macrophages
- (2018) Saveg Yadav et al. BIOMEDICINE & PHARMACOTHERAPY
- The specific role of O6-methylguanine-DNA methyltransferase inhibitors in cancer chemotherapy
- (2018) Guohui Sun et al. Future Medicinal Chemistry
- Antitumor action of 3-bromopyruvate implicates reorganized tumor growth regulatory components of tumor milieu, cell cycle arrest and induction of mitochondria-dependent tumor cell death
- (2018) Saveg Yadav et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- 3-Bromopyruvate as an Alternative Option for the Treatment of Protothecosis
- (2018) Tomasz Jagielski et al. Frontiers in Pharmacology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Enhancing anticancer effects, decreasing risks and solving practical problems facing 3-bromopyruvate in clinical oncology: 10 years of research experience
- (2018) Salah Mohamed El Sayed International Journal of Nanomedicine
- Valproate sensitizes human glioblastoma cells to 3-bromopyruvate-induced cytotoxicity
- (2018) Yuri Ishiguro et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- 3‑Bromopyruvate sensitizes human breast cancer cells to TRAIL‑induced apoptosis via the phosphorylated AMPK‑mediated upregulation of DR5
- (2018) Yuzhong Chen et al. ONCOLOGY REPORTS
- Positron emission tomography/computed tomography in the diagnosis, staging, and prognostic evaluation of natural killer/T-cell lymphoma
- (2018) Jian-Jun Ding et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- The potential of combi-molecules with DNA-damaging function as anticancer agents
- (2017) Guohui Sun et al. Future Medicinal Chemistry
- 3-Bromopyruvate treatment induces alterations of metabolic and stress-related pathways in glioblastoma cells
- (2017) Davide Chiasserini et al. Journal of Proteomics
- The promising anticancer drug 3-bromopyruvate is metabolized through glutathione conjugation which affects chemoresistance and clinical practice: An evidence-based view
- (2017) Salah Mohamed El Sayed et al. MEDICAL HYPOTHESES
- PKM2 methylation by CARM1 activates aerobic glycolysis to promote tumorigenesis
- (2017) Fabao Liu et al. NATURE CELL BIOLOGY
- 3-bromopyruvate and buthionine sulfoximine effectively kill anoikis-resistant hepatocellular carcinoma cells
- (2017) Minjong Lee et al. PLoS One
- The anticancer agent 3-bromopyruvate: a simple but powerful molecule taken from the lab to the bedside
- (2016) J. Azevedo-Silva et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- ABCB1-overexpressing MDCK-II cells are hypersensitive to 3-bromopyruvic acid
- (2016) Izabela Sadowska-Bartosz et al. LIFE SCIENCES
- The HK2 Dependent “Warburg Effect” and Mitochondrial Oxidative Phosphorylation in Cancer: Targets for Effective Therapy with 3-Bromopyruvate
- (2016) Paweł Lis et al. MOLECULES
- Anticancer agent 3-bromopyruvic acid forms a conjugate with glutathione
- (2016) Izabela Sadowska-Bartosz et al. Pharmacological Reports
- Candidate cancer drug suspected after death of three patients at an alternative medicine clinic
- (2016) Hinnerk Feldwisch-Drentrup SCIENCE
- The Warburg Effect: How Does it Benefit Cancer Cells?
- (2016) Maria V. Liberti et al. TRENDS IN BIOCHEMICAL SCIENCES
- Glutathione may have implications in the design of 3-bromopyruvate treatment protocols for both fungal and algal infections as well as multiple myeloma
- (2016) Katarzyna Niedźwiecka et al. Oncotarget
- Effect of 3-Bromopyruvate and Atovaquone on Infection duringIn VitroInteraction of Toxoplasma gondii and LLC-MK2 Cells
- (2015) Loyze Paola O. de Lima et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The cytotoxicity of 3-bromopyruvate in breast cancer cells depends on extracellular pH
- (2015) João Azevedo-Silva et al. BIOCHEMICAL JOURNAL
- Targeting glycolysis by 3-bromopyruvate improves tamoxifen cytotoxicity of breast cancer cell lines
- (2015) Yasmin M. Attia et al. BMC CANCER
- Enhanced Antitumor Activity of 3-Bromopyruvate in Combination with Rapamycin In Vivo and In Vitro
- (2015) Q. Zhang et al. Cancer Prevention Research
- Abstract 2673: Idelalisib has activity at clinically achievable drug concentrations in a subset of ABC and GCB diffuse large B-cell lymphoma and transformed follicular lymphoma cell lines
- (2015) Jia Y. Liu et al. CANCER RESEARCH
- 3-Bromopyruvate induces rapid human prostate cancer cell death by affecting cell energy metabolism, GSH pool and the glyoxalase system
- (2015) Daniela Valenti et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Effect of 3-bromopyruvate acid on the redox equilibrium in non-invasive MCF-7 and invasive MDA-MB-231 breast cancer cells
- (2015) Ewa Kwiatkowska et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Advances in Mycobacterial Isocitrate Lyase Targeting and Inhibitors
- (2015) M. Kratky et al. CURRENT MEDICINAL CHEMISTRY
- The antitumor agent 3-bromopyruvate has a short half-life at physiological conditions
- (2014) Matthew Glick et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Investigations on the Effect of O6-Benzylguanine on the Formation of dG-dC Interstrand Cross-Links Induced by Chloroethylnitrosoureas in Human Glioma Cells Using Stable Isotope Dilution High-Performance Liquid Chromatography Electrospray Ionization Tandem Mass Spectrometry
- (2014) Guohui Sun et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Systemic Delivery of Microencapsulated 3-Bromopyruvate for the Therapy of Pancreatic Cancer
- (2014) J. Chapiro et al. CLINICAL CANCER RESEARCH
- 3-bromopyruvate inhibits glycolysis, depletes cellular glutathione, and compromises the viability of cultured primary rat astrocytes
- (2014) Eric Ehrke et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Glycolysis inhibition and its effect in doxorubicin resistance in neuroblastoma
- (2014) Jonathan F. Bean et al. JOURNAL OF PEDIATRIC SURGERY
- Local delivery of cancer-cell glycolytic inhibitors in high-grade glioma
- (2014) Robert T. Wicks et al. NEURO-ONCOLOGY
- The Reversal Effects of 3-Bromopyruvate on Multidrug Resistance In Vitro and In Vivo Derived from Human Breast MCF-7/ADR Cells
- (2014) Long Wu et al. PLoS One
- 3-Bromopyruvate: A novel antifungal agent against the human pathogen Cryptococcus neoformans
- (2013) Mariusz Dyląg et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Antiglycolytic Therapy Combined with an Image-guided Minimally Invasive Delivery Strategy for the Treatment of Breast Cancer
- (2013) Manon Buijs et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- The Expression of Glyceraldehyde-3-Phosphate Dehydrogenase Associated Cell Cycle (GACC) Genes Correlates with Cancer Stage and Poor Survival in Patients with Solid Tumors
- (2013) Dunrui Wang et al. PLoS One
- Aerosolized 3-Bromopyruvate Inhibits Lung Tumorigenesis without Causing Liver Toxicity
- (2012) Q. Zhang et al. Cancer Prevention Research
- Novel insight into the role of GAPDH playing in tumor
- (2012) Chunmei Guo et al. Clinical & Translational Oncology
- Erratum to: Experimental results using 3-bromopyruvate in mesothelioma: in vitro and in vivo studies
- (2012) Philippe Icard et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Over-expression of GAPDH in human colorectal carcinoma as a preferred target of 3-Bromopyruvate Propyl Ester
- (2012) Zhenjie Tang et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- A translational study “case report” on the small molecule “energy blocker” 3-bromopyruvate (3BP) as a potent anticancer agent: from bench side to bedside
- (2012) Y. H. Ko et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Targeting aerobic glycolysis: 3-bromopyruvate as a promising anticancer drug
- (2012) Simone Cardaci et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- 3-bromopyruvate: Targets and outcomes
- (2012) Maria C. Shoshan JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors
- (2012) Kivanç Birsoy et al. NATURE GENETICS
- Separate and concurrent use of 2-deoxy-D-glucose and 3-bromopyruvate in pancreatic cancer cells
- (2012) HUIJIE XIAO et al. ONCOLOGY REPORTS
- Human Hepatocellular Carcinoma in a Mouse Model: Assessment of Tumor Response to Percutaneous Ablation by Using Glyceraldehyde-3-Phosphate Dehydrogenase Antagonists
- (2012) Shanmugasundaram Ganapathy-Kanniappan et al. RADIOLOGY
- Final results of a prematurely discontinued Phase 1/2 study of eniluracil with escalating doses of 5-fluorouracil administered orally in patients with advanced hepatocellular carcinoma
- (2011) Gilberto de Lima Lopes et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Intracellular ATP Levels Are a Pivotal Determinant of Chemoresistance in Colon Cancer Cells
- (2011) Y. Zhou et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- The monocarboxylate transporter family-Role and regulation
- (2011) Andrew P. Halestrap et al. IUBMB LIFE
- Targeting cancer metabolism: a therapeutic window opens
- (2011) Matthew G. Vander Heiden NATURE REVIEWS DRUG DISCOVERY
- Glycolysis Inhibition Inactivates ABC Transporters to Restore Drug Sensitivity in Malignant Cells
- (2011) Ayako Nakano et al. PLoS One
- 3-Bromopyruvate induces necrotic cell death in sensitive melanoma cell lines
- (2010) J.-Z. Qin et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The diverse functions of GAPDH: Views from different subcellular compartments
- (2010) Carlos Tristan et al. CELLULAR SIGNALLING
- The combination of the novel glycolysis inhibitor 3-BrOP and rapamycin is effective against neuroblastoma
- (2010) Alejandro G. Levy et al. INVESTIGATIONAL NEW DRUGS
- Human pyruvate kinase M2: A multifunctional protein
- (2010) Vibhor Gupta et al. PROTEIN SCIENCE
- Identification of small molecule inhibitors of pyruvate kinase M2
- (2009) Matthew G. Vander Heiden et al. BIOCHEMICAL PHARMACOLOGY
- Role of mitochondria-associated hexokinase II in cancer cell death induced by 3-bromopyruvate
- (2009) Zhao Chen et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Transport by SLC5A8 with subsequent inhibition of histone deacetylase 1 (HDAC1) and HDAC3 underlies the antitumor activity of 3-bromopyruvate
- (2009) Muthusamy Thangaraju et al. CANCER
- LDH correlation with survival in advanced melanoma from two large, randomised trials (Oblimersen GM301 and EORTC 18951)
- (2009) Sanjiv S. Agarwala et al. EUROPEAN JOURNAL OF CANCER
- Targets of 3-Bromopyruvate, A New, Energy Depleting, Anticancer Agent
- (2009) P. Dell'Antone Medicinal Chemistry
- Analyses of Resected Human Brain Metastases of Breast Cancer Reveal the Association between Up-Regulation of Hexokinase 2 and Poor Prognosis
- (2009) D. Palmieri et al. MOLECULAR CANCER RESEARCH
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- Sodium-coupled Monocarboxylate Transporters in Normal Tissues and in Cancer
- (2008) Vadivel Ganapathy et al. AAPS Journal
- Inhibition of energy-producing pathways of HepG2 cells by 3-bromopyruvate1
- (2008) Ana Paula Pereira Da Silva et al. BIOCHEMICAL JOURNAL
- Synergistic Antipancreatic Tumor Effect by Simultaneously Targeting Hypoxic Cancer Cells With HSP90 Inhibitor and Glycolysis Inhibitor
- (2008) X. Cao et al. CLINICAL CANCER RESEARCH
- Glycolytic enzyme inhibitors in cancer treatment
- (2008) Roberto Scatena et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice
- (2008) Pierre Sonveaux et al. JOURNAL OF CLINICAL INVESTIGATION
- 3-Bromopyruvate as inhibitor of tumour cell energy metabolism and chemopotentiator of platinum drugs
- (2008) Linda Strandberg Ihrlund et al. Molecular Oncology
- Pyruvate kinase M2 is a phosphotyrosine-binding protein
- (2008) Heather R. Christofk et al. NATURE
- The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
- (2008) Heather R. Christofk et al. NATURE
- Hexokinase-2 bound to mitochondria: Cancer's stygian link to the “Warburg effect” and a pivotal target for effective therapy
- (2008) Saroj P. Mathupala et al. SEMINARS IN CANCER BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation